Cross-Sector entity
The 35-day window averages about 4 stories each week. The busiest single day carried 7. Of the tracked stories, 5 of 20 also mention Bitcoin, the most common co-covered peer. Coverage clusters in markets, which accounts for 8 of those 20, with the remainder spread across 7 other categories.
236 verified stories tracked
Last mentioned: 1d ago
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 30 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
The 35-day window averages about 4 stories each week. The busiest single day carried 7. Of the tracked stories, 5 of 20 also mention Bitcoin, the most common co-covered peer. Coverage clusters in markets, which accounts for 8 of those 20, with the remainder spread across 7 other categories. The tracked stories average 2.1 original sources each. 0% of these stories carry negative sentiment. We currently track 20 Cross-Sector stories that mention Nasdaq, published between September 5, 2026 and October 9, 2026.
Computed from the 20 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Nasdaq. Shared-story counts are live from our verified record — not editorial picks.
Zero-Emission Deadline
New York target for a 100% zero-emission electricity sector.
NY State Storage Target
Deadline for New York to reach its 6 GW energy storage capacity goal.
Potential extended filing deadline
If Nasdaq approves the compliance plan, FMAC could receive an extension until this date to file the late quarterly report.
Compliance plan due to Nasdaq
FMAC must submit a plan to regain compliance with Nasdaq listing requirements by this date.
Nasdaq CEO addresses TOKEN2049 in Singapore
Adena Friedman tells CNBC's Joanna Ossinger that tokenizing Treasurys, equities, money market funds, and money flow could unlock tens of billions of dollars in trapped collateral and help move markets toward 24/7 trading.
Potential Extension
Aptorum may apply for a second 180-day period if compliance is not met but criteria are satisfied.
Pilot Program
Expected launch of a pilot program for select S&P 500 stocks on the new DLT infrastructure.
Lockup Expiration Window
An estimated $800 billion in insider and early-investor shares become eligible for sale, the dominant risk factor for SPCX.
Medpace Stock Declines 4.2%
MEDP shares traded down $26.10 to $598.08 on volume of 232,765 shares, below average.
CEO Sells 21,966 Shares
Troendle sold 21,966 shares at an average price of $625.47 for $13,739,074.02, reducing his position 6.10% to 338,225 shares.
FMAC discloses Nasdaq compliance notice
Future Money Acquisition Corp announced receipt of a Nasdaq listing deficiency notice over the delayed 10-Q filing.
Trump-Xi summit scheduled
US President Donald Trump and Chinese President Xi Jinping are expected to focus on trade and artificial intelligence.
Asian markets follow Wall Street higher
South Korea's Kospi rises 1.7% and Taiwan's Taiex gains 1.4% in early trading after Meta shares surge 11% on Muse's chart-topping success.
Nasdaq rallies 2.3%
Wall Street's tech-heavy Nasdaq composite finishes the session 2.3 percent higher.
US-China trade and AI talks in New York
Chinese trade negotiator He Lifeng and the US Treasury Secretary meet in New York to lay groundwork for the upcoming summit.
$110 million funding round announced
Kaiko announces a $110 million round led by S&P Global, with participation from BNP Paribas, Nasdaq, Royal Bank of Canada, Bpifrance, and Susquehanna.
Compliance Deadline
Final date for CXApp to meet the minimum bid price requirement or face delisting.
Initial Compliance Deadline
End of the first 180-day grace period to regain a $1.00 closing bid price.
Meta releases Muse AI agent
Meta launches its free AI agent Muse, designed for users with no technical background and capable of booking travel, sending emails, and making purchases.
Q2 2026 Results and Business Update
Datavault AI reports Q2 2026 results and reiterates a full-year 2026 revenue target of at least $200 million.
Nasdaq CEO Adena Friedman says tokenizing Treasurys, equities, and money market funds could free tens of billions in trapped collateral and accelerate 24/7 trading, with AI agents handling continuous risk management. The convergence of stablecoin regulation and retail demand creates a multi-year infrastructure opportunity for banks, exchanges, and asset managers.
Source: CNBC · Seeking Alpha
Medpace CEO August Troendle sold 24,376 shares for $15.2M across two late-September transactions, with MEDP dipping to $598.08. For health system and IT leaders tracking CRO capacity, insider selling adds a signal to watch alongside strong Q2 growth of 17.2%.
Medpace CEO August Troendle sold $15.23M in MEDP shares over two days, and the stock dropped 4.2% to $598.08. With a 35x PE and 2.78 PEG, investors must weigh strong Q2 earnings against insider selling near the stock's $677.90 high.
Two SEC filings reveal Medpace CEO August Troendle offloaded $15.2M in stock as the CRO trades near its 52-week high. For biopharma teams, Medpace's Q2 revenue growth of 17.2% and $707.3M revenue remain robust, but insider sales deserve attention amid rising trial outsourcing.
Source: themarketsdaily.com · tickerreport.com
Index inclusion is a liquidity event. The Motley Fool lists AST SpaceMobile and Intuitive Machines as potential Nasdaq-100 additions by 2030 after SpaceX reported a $2 trillion debut. For investors, the debate is whether current valuations can expand fast enough to meet index thresholds and attract passive flows.
SpaceX's reported $2 trillion market cap and fast Nasdaq-100 inclusion mark space's arrival in mainstream markets. The next candidates—AST SpaceMobile and Intuitive Machines—represent direct-to-device connectivity and lunar infrastructure bets that could reshape the sector's investable universe by 2030.
Scienture Holdings and Clearmind Medicine both execute reverse stock splits effective Oct. 5, 2026. SCNX's 1-for-25 split lifts its $0.18 stock to $4.50, while CMND's 1-for-8 split lifts $0.72 to $5.76, aiming to restore Nasdaq's $1 minimum bid.
Clearmind Medicine, a microcap biotech developing psychedelic-derived MEAI for alcohol use disorder, will execute a 1-for-8 reverse split on Oct. 5. The move mechanically lifts its $0.72 price to roughly $5.76, aiming to restore Nasdaq compliance as clinical-stage losses continue.
Source: themarketsdaily.com · dailypolitical.com
Oura's last-minute IPO postponement despite 74% year-on-year growth shows how competitive pressure from Apple and Google is reshaping wearable health funding, raising doubts about pure-play health hardware sustainability.
Source: irishtimes.com · Sifted
Six brokerages rate Canaan a Moderate Buy with five buy calls and one sell. The average target of $1.92 is far above the $0.39 spot price, but negative margins and a beta of 2.72 complicate the bullish case.
Canaan's ASIC mining hardware business is at the center of a Moderate Buy consensus, but the company's latest quarter shows a 67.78% negative net margin on $31.86 million in revenue. For Web3 participants, the stock is a leveraged proxy for Bitcoin mining economics, with a beta of 2.72 and 70.14% institutional ownership.
Source: Ticker Report · Daily Political
FMAC must submit a Nasdaq compliance plan by Nov. 23, 2026, after failing to file its 10-Q for the period ended July 31. With a $159M market cap and zero revenue, the SPAC's listing and deal-making capacity are at risk. Investors are watching whether an extension to March 22, 2027 will be granted.
Source: gurufocus.com · Seeking Alpha
Meta shares jumped 11% after its consumer AI agent Muse topped charts, lifting the Nasdaq 2.3% and Asian tech indices. Falling oil prices added to risk-on sentiment ahead of the Trump-Xi summit.
Meta's free consumer AI agent Muse topped download charts after launching in September 2026, driving an 11% stock surge. Muse handles travel, email, and purchases through WhatsApp or a dedicated app, signaling a shift toward mainstream agentic AI.
Source: thejakartapost.com · finance.yahoo.com
Kaiko, a crypto data company founded in France in 2014, raised a $110 million round led by S&P Global with Nasdaq, BNP Paribas, RBC, Bpifrance, and Susquehanna participating. The New York-based company will use the capital to expand its data platform covering 150+ exchanges. The round reflects a shift from venture-only backing to strategic institutional investors.
Crypto data provider Kaiko raised $110 million led by S&P Global, with BNP Paribas, Nasdaq, RBC, Bpifrance, and Susquehanna joining. The funding will expand Kaiko's data coverage across more than 150 exchanges and protocols. It highlights growing demand for institutional-grade crypto data as tokenisation of real-world assets gathers pace.
S&P Global led a $110 million round in crypto data provider Kaiko, joined by BNP Paribas, Nasdaq, Royal Bank of Canada, Bpifrance, and Susquehanna. The deal signals that major financial institutions are investing directly in digital asset data infrastructure even as crypto prices remain below their late-2025 peak. Kaiko will use the capital to expand coverage beyond 150 exchanges and protocols.
Source: CNA · Elizabeth Howcroft
Oil's pullback to $103.74 masks a still-hot energy week: Brent is up 8%, U.S. diesel hit a record $6 a gallon, and Saudi supply is at a three-decade low just as CPI lands. Markets are repricing inflation risk and Fed expectations in real time.
Source: newsday.com · isp.netscape.com
bioAffinity's CyPath Lung test volume grew 216% year over year, and the company is now expanding into post-treatment surveillance for lung-cancer patients. The move could widen the test's clinical role beyond initial diagnostic decisions.
A 1-for-15 reverse split and a surveillance announcement produced a 47.95% one-day jump for thinly traded bioAffinity Technologies. But only $2.4 million in cash and a warrant overhang complicate the move's sustainability.
